168 related articles for article (PubMed ID: 7471074)
1. Antitumor activity of L-canavanine against L1210 murine leukemia.
Green MH; Brooks TL; Mendelsohn J; Howell SB
Cancer Res; 1980 Mar; 40(3):535-7. PubMed ID: 7471074
[TBL] [Abstract][Full Text] [Related]
2. Effects on the monocyte-macrophage system and antitumor activity against L1210 leukemia of cis-bis-cyclopentenecarboxylato-trans-R,R-1,2-diaminocyclohexane -platinum (II) encapsulated in multilamellar vesicles.
Perez-Soler R; Khokhar AR; Claringbold P; Kasi LP; Lopez-Berestein G
J Natl Cancer Inst; 1986 Nov; 77(5):1137-43. PubMed ID: 2430132
[TBL] [Abstract][Full Text] [Related]
3. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
[TBL] [Abstract][Full Text] [Related]
5. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
Panasci LC; Green D; Schein PS
J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of human tumor cell killing by L-canavanine in combination with gamma-radiation.
Green MH; Ward JF
Cancer Res; 1983 Sep; 43(9):4180-2. PubMed ID: 6871859
[TBL] [Abstract][Full Text] [Related]
7. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.
Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
Kinahan JJ; Pavelic ZP; Leonard RJ; Bloch A; Grindey GB
Cancer Res; 1980 Mar; 40(3):598-603. PubMed ID: 7471080
[TBL] [Abstract][Full Text] [Related]
10. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
Chou TC; Schmid FA; Feinberg A; Philips FS; Han J
Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591
[TBL] [Abstract][Full Text] [Related]
11. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
[TBL] [Abstract][Full Text] [Related]
12. Bioactivity of synthetic 2-halo-3-aryl-4(3H)-quinazoliniminium halides in L1210 leukemia and SK-BR-3 mammary tumor cells in vitro.
Perchellet JP; Waters AM; Perchellet EM; Naganaboina VK; Chandra KL; Desper J; Rayat S
Anticancer Res; 2011 Jun; 31(6):2083-93. PubMed ID: 21737626
[TBL] [Abstract][Full Text] [Related]
13. Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia.
Morin MJ; Bernacki RJ
Cancer Res; 1983 Apr; 43(4):1669-74. PubMed ID: 6339042
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of a rat colon tumor by L-canavanine.
Thomas DA; Rosenthal GA; Gold DV; Dickey K
Cancer Res; 1986 Jun; 46(6):2898-903. PubMed ID: 3698016
[TBL] [Abstract][Full Text] [Related]
16. In vivo antitumor activity of the bitter melon (Momordica charantia).
Jilka C; Strifler B; Fortner GW; Hays EF; Takemoto DJ
Cancer Res; 1983 Nov; 43(11):5151-5. PubMed ID: 6616452
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
Guo QL; Wu MS; Chen Z
Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of DL-threo-beta-fluoroasparagine against human leukemia cells in culture and L1210 cells in DBA mice.
Stern AM; Abeles RH; Tashjian AH
Cancer Res; 1984 Dec; 44(12 Pt 1):5614-8. PubMed ID: 6498822
[TBL] [Abstract][Full Text] [Related]
19. Effects of cannabinoids on L1210 murine leukemia. 1. Inhibition of DNA synthesis.
Tucker AN; Friedman MA
Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):703-14. PubMed ID: 897352
[TBL] [Abstract][Full Text] [Related]
20. Action of free radical in podophyllic acid piperindyl hydrazone nitroxide radical on its antitumor activity and toxicity.
Jia ZP; Wang R; Xie JW; Xu LT
Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):571-6. PubMed ID: 10678157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]